iSpecimen Inc. (ISPC)
NCM · Healthcare · Diagnostics & Research
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
About iSpecimen Inc.
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 713K | 107K | 52K | 156K |
| Gross Profit | 269K | -98K | -547K | 72K |
| Operating Income | -1.8M | -2.8M | -2.7M | -2.5M |
| Net Income | -1.0M | -2.8M | -5.0M | -2.3M |
| Diluted EPS | $-16.80 | $-19.20 | $nan | $-266.40 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 10.4M | 9.9M | 9.3M | 1.9M |
| Gross Profit | 5.6M | 5.1M | 4.0M | 24K |
| Operating Income | -10.2M | -11.2M | -12.7M | -9.0M |
| Net Income | -10.2M | -11.1M | -12.5M | -10.5M |
| Diluted EPS | $-928.00 | $-982.00 | $-703.20 | $-91.20 |